Across TCGA pan-cancer cohorts, LINC01310 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC01310’s most consistent transcriptional readouts.

The strongest signal is observed in prostate adenocarcinoma (PRAD), where LINC01310 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01310 is over-expressed in tumor, although a few such as PRAD and LUAD show the opposite, repressed pattern.

PRAD and LUAD are the cancer types where LINC01310 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01310 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PRAD	All	All	−0.278	.011	2	view →
LUAD	All	All	−0.014	.023	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: LINC01310 RNA expression & survival · all LINC01310 data types